Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenylate kinase 2 | 0.678 | 0.423 | 6.3E-05 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
AKNA domain containing 1 | 0.890 | 0.269 | 3.6E-23 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
barttin CLCNK type accessory subunit beta | 0.603 | 0.692 | 1.1E-10 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2006 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2009 | ||||||||
|
cadherin related 23 | 0.539 | 0.769 | 3.2E-06 |
|
phenotype | 0.100 | None | 0 | 2 | |||||||||||
|
calcium voltage-gated channel subunit alpha1 D | 0.582 | 0.577 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
cell division cycle 14A | 0.736 | 0.385 | 9.6E-08 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
chloride voltage-gated channel Ka | 0.711 | 0.385 | 4.2E-17 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
claudin 14 | 0.705 | 0.462 | 1.1E-04 |
|
phenotype | 0.400 | None | 1.000 | 1 | 1 | 2001 | 2001 | ||||||||
|
cochlin | 0.659 | 0.385 | 1.2E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
DNA polymerase delta 1, catalytic subunit | 0.507 | 0.769 | 2.4E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
epidermal growth factor receptor pathway substrate 8 | 0.608 | 0.615 | 0.97 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
espin | 0.700 | 0.385 | 2.9E-09 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2004 | 2006 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
forkhead box I1 | 0.686 | 0.462 | 0.77 |
|
phenotype | 0.300 | moderate | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
G protein signaling modulator 2 | 0.682 | 0.538 | 7.7E-11 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
gap junction protein beta 2 | 0.441 | 0.846 | 6.6E-16 |
|
phenotype | 0.450 | None | 1.000 | 6 | 1 | 2002 | 2008 | ||||||||
|
gap junction protein beta 3 | 0.621 | 0.462 | 2.2E-03 |
|
phenotype | 0.500 | strong | 1.000 | 2 | 0 | 1998 | 1999 | ||||||||
|
gap junction protein beta 6 | 0.528 | 0.808 | 1.7E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2006 | ||||||||
|
glutaredoxin and cysteine rich domain containing 1 | 0.861 | 0.115 | 3.9E-11 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
immunoglobulin like domain containing receptor 1 | 0.729 | 0.346 | 2.6E-12 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
jagged canonical Notch ligand 1 | 0.429 | 0.808 | 1.00 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
lipoxygenase homology domains 1 | 0.792 | 0.231 | 5.6E-26 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
MARVEL domain containing 2 | 0.705 | 0.462 | 1.3E-12 |
|
phenotype | 0.100 | None | 0 | 1 |